RYBOX Mutual Fund

RYBOX Mutual Fund

NAV$75.38

Fund Essentials - as of Mar 31, 2026

Net Assets
$16M
Expense Ratio
1.63%
Dividend Yield (Current)
13.20%
Holdings
75
Inception Date
Sep 1, 2004
Fund Family
Rydex Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+15.02%
1 Year+47.04%
3 Year+16.93%
5 Year+5.45%
10 Year+8.53%

Asset Allocation

Stocks: 99.55%
Bonds: 0.44%

Top Holdings

View All →
TickerNameWeight
ABBVAbbvie Inc.7.39%
AMGNAmgen Inc.5.23%
GILDGilead Sciences4.96%
VRTXNvaesrtex Pharmaceuticals Inc4.01%
REGNRegeneron Pharmaceuticals, Inc.3.56%
Top 10 Concentration: 36.65%Report Date: Mar 31, 2026
Download all 75 holdings for RYBOX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
13.20%
Frequency
Annually
Latest Distribution
$15.77
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
FundXLS Pro
See how RYBOX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
X-ray my whole portfolio$45/quarter Pro · Cancel anytime
From MarketXLS, trusted since 2014.

RYBOX Mutual Fund Overview

RYBOX Mutual Fund (Rydex Biotechnology Fund Class A) is managed by Rydex Funds with $16.5M in net assets. RYBOX expense ratio is 1.63%, holding 75 positions across sectors including Health Care. Inception date: 2004-09-01.

RYBOX performance shows a YTD return of 15.02%. The 1-year return is 47.04% and the 5-year return is 5.45%. RYBOX dividend yield stands at 13.20%, paid annually.

RYBOX top holdings include Abbvie Inc. (7.4%), Amgen Inc. (5.2%), Gilead Sciences (5.0%), Nvaesrtex Pharmaceuticals Inc (4.0%), Regeneron Pharmaceuticals, Inc. (3.6%). Go to all RYBOX holdings, RYBOX sectors, or RYBOX dividends.

RYBOX can be compared against other funds. Use RYBOX overlap to find shared positions, or RYBOX vs another fund for a side-by-side view. RYBOX alternatives are available via the screener, along with tax-loss harvesting opportunities.